Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries

Parkinsonism and Related Disorders

Volumn 20, Issue 9, 2014, Pages 969-974

  Hechtner, Marlene C ^a,b   Vogt, Thomas ^c   Zöllner, York ^d   Schröder, Sabrina ^e   Sauer, Julia B ^f   Binder, Harald ^a   Singer, Susanne ^a,g   Mikolajczyk, Rafael ^h,i  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d HAMBURG UNIVERSITY OF APPLIED SCIENCES   (Germany)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f University of Georgia   (United States)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Dyskinesia; Europe; Motor complications; Motor fluctuations; Parkinson's disease; Quality of life

Indexed keywords

ADULT; ANXIETY; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE DURATION; DYSKINESIA; DYSTONIA; EUROPE; EUROQOL 5 DIMENSION; FEMALE; FRANCE; GERMANY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE 39; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY ANALYSIS; SPAIN; STIGMA; SYMPTOMATOLOGY; UNITED KINGDOM; AGED; COMPLICATION; DYSKINESIAS; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; VERY ELDERLY;

ANTIPARKINSON AGENT;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DYSKINESIAS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 84906310210     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.06.001     Document Type: Article

References (30)

1. American Medical Directors Association (AMDA) Parkinson's disease in the long-term care setting 2010, 37. AMDA, Columbia, MD.
2. Eggert K., Oertel W., Reichmann H., Arnold G., Baas H., Berg D., et al. Leitlinien: (German): Parkinson-Syndrome - Diagnstik und Therapie 2012, 69. [accessed 13.03.13]. Available from: URL. http://www.awmf.org/leitlinien/detail/ll/030-010.html.
3. Oertel W.H., Berardelli A., Bloem B.R., Bonuccelli U., Burn D., Deuschl G., et al. Early (uncomplicated) parkinson's disease. European handbook of neurological management 2011, 217-236. Wiley-Blackwell, Oxford, UK. N.E. Gilhus, M.P. Barnes, M. Brainin (Eds.).
4. Müller T., Russ H. Levodopa, motor fluctuations and dyskinesia in parkinson's disease. Expert Opin Pharmacother 2006, 7:1715-1730.
5. Thanvi B.R., Lo T.C. Long term motor complications of levodopa: clinical features, mechanisms, and management strategies. Postgrad Med J 2004, 80:452-458.
6. Stocchi F. The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of parkinson's disease. Parkinsonism Relat Disord 2009, 15(Suppl.1):S9-S15.
7. World Health Organization (WHO) Neurological disorders - public health challenges 2006, 232. World Health Organization, Geneva, Switzerland.
8. Ahlskog J.E., Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001, 16:448-458.
9. Fox S.H., Lang A.E. Levodopa-related motor complications - phenomenology. Mov Disord 2008, 23(Suppl.3):S509-S514.
10. Martignoni E., Riboldazzi G., Calandrella D., Riva N. Motor complications of parkinson's disease. Neurol Sci 2003, 24(Suppl.1):S27-S29.
11. Soh S.E., Morris M.E., McGinley J.L. Determinants of health-related quality of life in parkinson's disease: a systematic review. Parkinsonism Relat Disord 2011 Jan, 17:1-9.
12. Anderson P., Benford M., Harris N., Karavali M., Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understand. Curr Med Res Opin 2008, 24:3063-3072.
13. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990, 16:199-208. EuroQol Group.
14. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a parkinson's disease summary index score. Age Ageing 1997, 26:353-357.
15. Schrag A., Selai C., Jahanshahi M., Quinn N.P. The EQ-5D - a generic quality of life measure-is a useful instrument to measure quality of life in patients with parkinson's disease. JNeurol Neurosurg Psychiatr 2000, 69:67-73.
16. Martinez-Martin P., Serrano-Dueñas M., Forjaz M.J., Serrano M.S. Two questionnaires for parkinson's disease: are the PDQ-39 and PDQL equivalent?. Qual Life Res 2007, 16:1221-1230.
17. Greiner W., Weijnen T., Nieuwenhuizen M., Oppe S., Badia X., Busschbach J., et al. Asingle European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 2003, 4:222-231.
18. Jenkinson C., Fitzpatrick R., Peto V., Harris R., Saunders P. The parkinson's disease questionnaire 2008, 114. Health Services Research Unit University of Oxford, Oxford.
19. Gunzler SA, Nutt JG. Motor fluctuations and dyskinesia. In: Factor SA, Weiner WJ, editors. parkinson's disease. Diagnosis and clinical management. New York: Demos, 2008. p. 575-584.
20. Dodel R.C., Berger K., Oertel W.H. Health-related quality of life and healthcare utilisation in patients with parkinson's disease: impact of motor fluctuations and dyskinesias. Pharmacoeconomics 2001, 19:1013-1038.
21. Chapuis S., Ouchchane L., Metz O., Gerbaud L., Durif F. Impact of the motor complications of parkinson's disease on the quality of life. Mov Disord 2005, 20:224-230.
22. Rahman S., Griffin H.J., Quinn N.P., Jahanshahi M. Quality of life in parkinson's disease: the relative importance of the symptoms. Mov Disord 2008, 23:1428-1434.
23. Winter Y., von Campenhausen S., Gasser J., Seppi K., Reese J.P., Pfeiffer K.P., et al. Social and clinical determinants of quality of life in parkinson's disease in Austria: a cohort study. JNeurol 2010, 257:638-645.
24. Winter Y., von Campenhausen S., Arend M., Longo K., Boetzel K., Eggert K., et al. Health-related quality of life and its determinants in parkinson's disease: results of an Italian cohort study. Parkinsonism Relat Disord 2011, 17:265-269.
25. Reuther M., Spottke E.A., Klotsche J., Riedel O., Peter H., Berger K., et al. Assessing health-related quality of life in patients with parkinson's disease in a prospective longitudinal study. Parkinsonism Relat Disord 2007, 13:108-114.
26. Winter Y., von Campenhausen S., Popov G., Reese J.P., Balzer-Geldsetzer M., Kukshina A., et al. Social and clinical determinants of quality of life in parkinson's disease in a Russian cohort study. Parkinsonism Relat Disord 2010, 16:243-248.
27. Bach J.P., Riedel O., Klotsche J., Spottke A., Dodel R., Wittchen H.U. Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with parkinson's disease. JNeurol Sci 2012, 314:41-47.
28. Rodríguez-Violante M., Cervantes-Arriaga A., Corona T., Martínez-Ramírez D., Morales-Briceño H., Martínez-Martín P. Clinical determinants of health-related quality of life in Mexican patients with parkinson's disease. Arch Med Res 2013, 44:110-114.
29. Organisation for Economic Co-operation and Development (OECD). OECD stat extracts. [accessed 10.07.10]. Available from: URL:. http://stats.oecd.org/Index.aspx.
30. Andlin-Sobocki P., Jönsson B., Wittchen H.U., Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005, 12(Suppl.1):1-27.